Search Results

Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders

Authors: Mancuso, M.; Orsucci, D.; Volpi, L.; Calsolaro, V.; Siciliano, G.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 111-121(11)

Publisher: Bentham Science Publishers

Recent development of acupuncture on Parkinson's disease

Authors: Joh, Tong H.; Park, Hi-Joon; Kim, Seung-Nam; Lee, Hyejung

Source: Neurological Research, Volume 32, Supplement 1, February 2010 , pp. 5-9(5)

Publisher: Maney Publishing

Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?

Authors: Correia, Sónia C.; Moreira, Paula I.

Source: Journal of Neurochemistry, Volume 112, Number 1, January 2010 , pp. 1-12(12)

Publisher: Blackwell Publishing

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

Authors: Forrest, Caroline M.; Mackay, Gillian M.; Stoy, Nicholas; Spiden, Sarah L.; Taylor, Rohan; Stone, Trevor W.; Darlington, L. Gail

Source: Journal of Neurochemistry, Volume 112, Number 1, January 2010 , pp. 112-122(11)

Publisher: Blackwell Publishing

Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure

Authors: Williams, B. Blairanne; Li, Daphne; Wegrzynowicz, Michal; Vadodaria, Bhavin K.; Anderson, Joel G.; Kwakye, Gunnar F.; Aschner, Michael; Erikson, Keith M.; Bowman, Aaron B.

Source: Journal of Neurochemistry, Volume 112, Number 1, January 2010 , pp. 227-237(11)

Publisher: Blackwell Publishing

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9

Authors: Koronyo-Hamaoui, Maya; Ko, MinHee K.; Koronyo, Yosef; Azoulay, David; Seksenyan, Akop; Kunis, Gilad; Pham, Michael; Bakhsheshian, Joshua; Rogeri, Patricia; Black, Keith L.; Farkas, Daniel L.; Schwartz, Michal

Source: Journal of Neurochemistry, Volume 111, Number 6, December 2009 , pp. 1409-1424(16)

Publisher: Blackwell Publishing

The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk

Author: Pedersen, Bente K.

Source: The Journal of Physiology, Volume 587, Number 23, December 2009 , pp. 5559-5568(10)

Publisher: Blackwell Publishing

Pathophysiology and management of diabetic retinopathy

Authors: Abu El-Asrar, Ahmed M; Al-Mezaine, Hani S; Ola, Mohammad Shamsul

Source: Expert Review of Ophthalmology, Volume 4, Number 6, December 2009 , pp. 627-647(21)

Publisher: Expert Reviews

Role of Infection in the Pathogenesis of Alzheimer's Disease: Implications for Treatment

Authors: Holmes, Clive; Cotterell, Darren

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 993-1002(10)

Publisher: Adis International

Zn²⁺ mediates ischemia-induced impairment of the ubiquitin-proteasome system in the rat hippocampus

Authors: Chen, Min; Chen, Qian; Cheng, Xue-Wen; Lu, Ting-Jia; Liu, Han-Xing; Jia, Jie-Min; Zhang, Chi; Xu, Li; Xiong, Zhi-Qi

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1094-1103(10)

Publisher: Blackwell Publishing

Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury

Authors: Shan, Yuexin; Liu, Baosong; Li, Lijun; Chang, Ning; Li, Lei; Wang, Hanbin; Wang, Dianshi; Feng, Hua; Cheung, Carol; Liao, Mingxia; Cui, Tianyuan; Sugita, Shuzo; Wan, Qi

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1149-1160(12)

Publisher: Blackwell Publishing

The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy

Authors: Zemlyak, Ilona; Manley, Nathan; Vulih-Shultzman, Inna; Cutler, Andrew B.; Graber, Kevin; Sapolsky, Robert M.; Gozes, Illana

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1252-1263(12)

Publisher: Blackwell Publishing

Cannabinoids and Parkinson's Disease

Authors: Garcia-Arencibia, Moises; Garcia, Concepcion; Fernandez-Ruiz, Javier

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 432-439(8)

Publisher: Bentham Science Publishers

Glutamate Receptors as Therapeutic Targets for Parkinson's Disease

Authors: Johnson, Kari A.; Conn, P. J.; Niswender, Colleen M.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 475-491(17)

Publisher: Bentham Science Publishers

Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes

Authors: Katrych, Oleksandra; Simone, Tessa M.; Azad, Shara; Mousa, Shaker A.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 512-519(8)

Publisher: Bentham Science Publishers

Cannabinoids, multiple sclerosis and neuroprotection

Authors: de Lago, Eva; Gómez-Ruiz, María; Moreno-Martet, Miguel; Fernández-Ruiz, Javier

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 645-660(16)

Publisher: Expert Reviews

Activated astrocytes: a therapeutic target in Alzheimer's disease?

Authors: Fuller, Stacey; Münch, Gerald; Steele, Megan

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1585-1594(10)

Publisher: Expert Reviews

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors: Rezai-Zadeh, Kavon; Gate, David; Szekely, Christine A; Town, Terrence

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1623-1633(11)

Publisher: Expert Reviews

What is the association between depression and Alzheimer's disease?

Authors: Tsuno, Norifumi; Homma, Akira

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1667-1676(10)

Publisher: Expert Reviews

Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?

Authors: Muresan, Virgil; Muresan, Zoia

Source: Future Neurology, Volume 4, Number 6, November 2009 , pp. 761-773(13)

Publisher: Future Medicine